KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Gains from Investment Securities: 2018-2025

Historic Gains from Investment Securities for Guardant Health (GH) over the last 7 years, with Sep 2025 value amounting to $2.3 million.

  • Guardant Health's Gains from Investment Securities fell 21.19% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.2 million, marking a year-over-year increase of 209.09%. This contributed to the annual value of $15.7 million for FY2024, which is 40.05% up from last year.
  • Latest data reveals that Guardant Health reported Gains from Investment Securities of $2.3 million as of Q3 2025, which was down 69.48% from $7.4 million recorded in Q2 2025.
  • In the past 5 years, Guardant Health's Gains from Investment Securities registered a high of $170.8 million during Q1 2021, and its lowest value of $64,000 during Q2 2021.
  • Over the past 3 years, Guardant Health's median Gains from Investment Securities value was $3.1 million (recorded in 2023), while the average stood at $4.7 million.
  • Within the past 5 years, the most significant YoY rise in Guardant Health's Gains from Investment Securities was 8,630.05% (2021), while the steepest drop was 99.32% (2021).
  • Guardant Health's Gains from Investment Securities (Quarterly) stood at $314,000 in 2021, then surged by 332.80% to $1.4 million in 2022, then spiked by 127.01% to $3.1 million in 2023, then skyrocketed by 160.06% to $8.0 million in 2024, then decreased by 21.19% to $2.3 million in 2025.
  • Its last three reported values are $2.3 million in Q3 2025, $7.4 million for Q2 2025, and $15.5 million during Q1 2025.